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Artikel Penelitian
ABSTRACT
Background: Yogyakarta Province is the only province in
Indonesia that piloted IPV immunization since September 2007.
Therefore, it is essential to evaluate the implementation of this
new program. This study was aimed to determine the cover-
age and timeliness of the IPV immunization after 2.5 years of
its introduction.
Method: A cross sectional study was carried out using the
WHO standard cluster sampling to estimate the immunization
coverage in urban Yogyakarta City and the remaining rural
districts in Yogyakarta Province. The subjects consisted of
children aged 12-23 months old and their parents. A question-
naire was used to acquire information from parents/caregivers
on demographic, socioeconomic, and IPV immunization status,
dates, location, and access of immunization.  Epi InfoTM 2003
software was used for data entry and analysis.
Result: Overall, 426 children were involved in the study (215
in urban and 211 in rural areas). The coverage for IPV1 through
IPV4 was 100%, 99.8%, 99.3%, and 96.7%, respectively. There
was no difference in coverage by urban/rural location, par-
ents’ education level, number of siblings, and distance to health
service. The coverage is very similar to that of survey in 2004
when this province still used oral polio vaccine. The mean
ages of IPV administration were 2.3, 3.5, 4.8, and 9.4 and no
significant difference among urban and rural areas was found.
More than 95% children received IPV immunization at appro-
priate age.
Conclusion: The IPV pilot project in Yogyakarta Province has
been implemented well with high coverage and appropriate
timeliness.
Keywords: immunization, polio eradication, IPV, coverage, time-
liness
ABSTRAK
Latar belakang: Propinsi Daerah Istimewa Yogyakarta adalah
satu-satunya propinsi di Indonesia yang melaksanakan pilot
project imunisasi IPV sejak September 2007. Evaluasi terhadap
program baru ini menjadi sangat penting. Penelitian ini bertujuan
untuk menentukan cakupan imunisasi IPV dan ketepatan waktu
pemberiannya, setelah 2,5 tahun dimulainya program ini.
Metode: Penelitian potong lintang dilakukan dengan meng-
gunakan metode sampling kluster standar WHO untuk menge-
tahui cakupan imunisasi di wilayah perkotaan Kota Yogyakarta
dan pedesaan di empat kabupaten lain di Propinsi Yogyakarta.
Subyek penelitian mencakup anak usia 12-23 bulan dan orang
tua mereka. Kuesioner dipergunakan untuk mendapatkan
informasi dari orang tua tentang faktor demografi, social
ekonomi, status imunisasi IPV, tanggal dan lokasi imunisasi dan
akses terhadap layanan imunisasi. Perangkat lunak Epi InfoTM
2003 dipergunakan untuk pengolahan dan analisis data.
Hasil: Sebanyak 426 anak ikut dalam penelitian, mencakup
215 anak di perkotaan dan 211 anak di pedesaan. Cakupan
imunisasi IPV untuk dosis 1-4 masing-masing 100%, 99,8%,
99,3%, dan 96,7%. Tidak ada perbedaan cakupan berdasarkan
lokasi perkotaan/pedesaan, tingkat pendidikan orang tua, jumlah
anak, dan jarak ke tempat layanan imunisasi. Angka cakupan
tersebut hampir sama dengan yang didapat pada survey tahun
2004 ketika propinsi ini masih menggunakan vaksin polio oral.
Rerata umur pemberian IPV dosis 1-4 masing-masing 2,3; 3,5;
4,4; dan 9,4 bulan. Lebih dari 95% anak mendapat imunisasi
IPV pada umur yang tepat.
Kesimpulan: Pilot project imunisasi IPV di Propinsi Yogyakarta
telah terlaksana dengan baik, dengan angka cakupan tinggi
dan umur pemberian yang tepat.
Kata kunci: imunisasi, eradikasi polio, IPV, cakupan, ketepatan
INTRODUCTION
The global strategy to eradicate polio virus has
been approaching its last phase. When the eradica-
tion of wild poliovirus has been achieved, the public
health benefits of routine immunization with oral po-
lio vaccine (OPV) will no longer outweigh the burden
of disease, either due to paralysis caused by OPV
(vaccine associated paralytic polio, VAPP), or by
outbreaks caused by circulating vaccine-derived po-
lioviruses (VDPV) resulting from mutation of the po-
lio vaccine virus. The VDPVs have been reported in
many countries, including Indonesia. Once global
certification of a polio-free status is achieved, the
eventual cessation of OPV use in routine immuniza-
tion program will become necessary to assure a last-
ing eradication of polio. However, it requires a good
strategy and timely approach. Switching the use of
OPV to inactivated polio vaccine (IPV) is one among
options for immunization policy in post-eradication
era.1,2,3
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Yogyakarta Province has been considered to
fulfill the requirements for the switching of OPV to
IPV immunization.4 The Indonesian Ministry of Health
has selected Yogyakarta as the only Province pi-
loted the use of IPV since September 2007. Follow-
ing this policy, it is important to evaluate the imple-
mentation and whether this switch compromises the
immunization program. This study was aimed to
determine the coverage and timeliness of the IPV
immunization after 2.5 years implementation of the
pilot program. This study would provide valuable in-
put for all stakeholders for continuation of this pro-
gram in Yogyakarta as well as its initiation in other
provinces in Indonesia.
METHOD
This was a community-based, cross-sectional
study. The study population consisted of parents of
children aged 12 to 23 months, born and living in the
study sites. We applied the standard cluster sam-
pling method of 30 clusters-by-7 subject, as recom-
mended by the World Health Organization (WHO)5,
to determine the coverage of IPV immunization in
Yogyakarta Province. The sampling design estimated
the immunization coverage within ± 10 percentage
points of true proportion with 95% confidence. The
population was classified into the municipality of
Yogyakarta and the four remaining districts (Bantul,
Gunungkidul, Kulonprogo, and Sleman), represent-
ing urban and rural areas, respectively. The popula-
tion was divided into sets of non-overlapping sub-
populations. Thirty villages in Yogyakarta City and
30 villages in the remaining four districts were se-
lected. For the selection of clusters, we used a prob-
ability proportionate to size approach, i.e. the vil-
lages with larger population have a higher probabil-
ity of being proportionately selected in the survey.
We excluded 122 among 391 villages in the four dis-
tricts from the sampling frame because the recent
report of Yogyakarta Central Statistics Bureau con-
sidered them as urban villages based on their devel-
opment level. The second stage of sampling ran-
domly selected a household in 1 cluster (defined as
1 village) from which all eligible subjects were
sampled. Experienced interviewers collected the
data. The interviewers were trained both in class-
room and field practice before data collection. After
visiting the first household, the surveyor moved on
to the next household and continued these ways
until 7 eligible subjects from each village were
sampled for the 30 selected villages. A questionnaire
was used to acquire information from parents/care-
givers on demographic, socioeconomic, and IPV
immunization status, dates, location, and access
of immunization. The information was mostly ac-
quired by direct interview, whereas the immuniza-
tion data was obtained from the immunization card.
The field work was carried out between July and
August 2010. We used Epi InfoTM 2003 software for
data entry and analysis.
Results
Overall, there were 426 children involved in this
study, including 215 in urban Yogyakarta City and
211 children in rural districts. Three hundred and
twenty six (84.78%) respondents were parents of
the children and 81.3% of respondents were able to
show the child’s immunization card.
The vast majority of mothers had education level
of secondary school, both in urban and rural areas
(70.4% and 74.4%, respectively). The proportion of
mothers with college/university education level is
significantly higher in urban than in rural areas (22.2%
vs 8.1%). In both study areas, the fathers are mostly
worked in private sector, whereas the mothers were
mostly housewives.
Most children received IPV immunization at pri-
mary health center (51.4%), with different patterns
in urban-rural areas. In urban areas, they received
immunization mostly at primary health center
(64.8%), followed by private hospital/clinic (18.1%)
and private midwife practice (10.2). Meanwhile, in
rural areas, private midwife practice being the pre-
dominant place (56.9%) for the children getting po-
lio immunization followed by primary health center
(37.4%) and private hospital/clinics (3.3%).
Table 1 shows high coverage for all IPV doses,
ranging from 96.7% to 100%. No differences in cove-
rage were found when the data were stratified by
urban or rural areas, distance to immunization ser-
vice, and number of sibling.
Table 1. Coverage (%) of IPV immunization by demographic factors
IPV 
doses 
Area Access distance Siblings Overall 
% (95% CI) Urban Rural ≤5 km >5 km ≤ 2 > 2 
IPV 1 100 100 100.0 100.0 100.0 100.0 100.0 (100.0-100.0)
IPV 2 99.5 100 99.8 100.0 99.7 100.0 99.8 (99.3-100.2) 
IPV 3 99.5 99.1 99.3 100.0 99.4 98.6 99.3 (98.5-100.1) 
IPV 4 99.5 97.2 96.5 100.0 96.9 97.1 96.7 (95.2-98.3)
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In comparison to the immunization coverage
survey conducted in 2004 for OPV, the present sur-
vey shows comparable high coverage of polio immu-
nization (Table 2).
Average ages of IPV administration for doses 1
through doses 4 are 2.3, 3.5, 4.8, and 9.4 months,
respectively, and very similar in both urban and rural
areas (Table 3)
In this study the IPV immunization was consid-
ered inappropriate when the first dose is given at
age less than 6 weeks and the interval between doses
are less than 24 days. It is based on the current
recommendation that the first dose of IPV should be
given at age of 6 weeks or more. The minimum inter-
val between doses is 4 weeks but administration
within 4 days earlier than the minimum recommended
interval is counted valid. Table 4 shows only small
portion of children received IPV immunization at in-
appropriate age (less than 5%).
DISCUSSION
The Indonesian Ministry of Health has chosen
Yogyakarta Province to introduce the IPV immuni-
zation program because of its high rates of vaccine
coverage, excellent program for surveillance of acute
flaccid paralysis (AFP) and a sewage system that
allows for environmental surveillance of poliovirus.
Previous survey has indicated a very high coverage
of the OPV immunization (99.5% in average). Sur-
veillance of acute flaccid paralysis (AFP) in
Yogyakarta in 2006 found AFP cases of 3/100.000
children aged under 15 years old and all were con-
firmed as non-polio cases. Environmental sewage
surveillance found the presence of circulating vac-
cine-type polio virus from all three types, in line with
the high coverage of OPV immunization. In addition,
serological study in 2004 revealed the presence of
protective level antibodies against all type of polio
viruses in under-five children.4
This study showed very high coverage of the
newly introduced IPV in Yogyakarta Province, which
is beyond 96% for all IPV doses both in urban and
rural areas. This coverage is very similar to that of
previous program when this Province applied polio
immunization using OPV. This achievement is much
impressive since switching policy from OPV to IPV
in several countries has been often compromise the
coverage, especially in developing countries. In
1980s, Senegal piloted the use of IPV in one of its
region in combined DTP-IPV form.6 The program in-
cluded two doses of IPV at interval of 6 months. The
two IPV doses induced protective antibody in 89%
children but the coverage was as low as 45% and
26% for the first and second IPV doses, respec-
tively. This poor achievement partly contributed to
the occurrence of polio outbreaks in the region 6-7
Table 2. Comparison of polio immunization coverage in 2004 and 2010 surveys*
Polio vaccine doses Urban area Rural area 2004 (%) 2010 (%) 2004 (%) 2010 (%) 
Polio 0¶ 100 - 99.5 - 
Polio 1 100 100 99.5 100 
Polio 2 99.5 99.5 99.5 100 
Polio 3 98.6 99.5 99.5 99.1 
Polio 4¶ - 96.3 - 97.2 
* Polio vaccine in 2004 and 210 surveys represent OPV and IPV immunizations, respectively.
¶ Polio-0 in 2004 survey indicates OPV given soon after birth, whereas polio-4 in 2010 survey does IPV given at 9 months old,
simultaneously with measles vaccine.
Table 3. Age of IPV administration
IPV 
doses 
Age of administration (months) 
Urban Rural Overall 
Range mean SD Range mean SD Range mean SD 
IPV 1 0.6-8.5 2.3 0.6 0.6-6.4 2.3 0.5 0.6-8.5 2.3 0.6 
IPV 2 2.2-11.1  3.6 0.8 2.0-7.6 3.5 0.7 2.0-11.1  3.5 0.8 
IPV 3 3.4-15.9 4.9 1.3 3.1-9.6 4.7 0.9 3.1-15.9 4.8 1.1 
IPV 4 5.1-18.7 9.8 1.6 4.5-12.3 9.3 0.9 4.5-18.7 9.4 1.8 
Table 4. Timeliness of IPV administration
Inappropriate timeliness Urban Rural Overall 
IPV1 < 6 weeks old 1.2 % 2.3 % 1.4 % 
Interval IPV1-IPV2 < 24 days 0.6% 0.6% 0.6% 
Interval IPV2-IPV3 < 24 days 0.6% 0.6% 0.6% 
Interval IPV3-IPV4 < 24 days 1.3% 2.4% 1.8% 
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years after the program. Similar finding was shown
in the introduction of a combined DTP–IPV vaccina-
tion in Burkina Faso, Africa.7 A two-dose schedule
induced antibodies in 90% of children, which per-
sisted for more than 2 years, but the vaccination
coverage was low (<60%) and circulation of poliovi-
rus in the community was not interrupted.
The homogeneous high coverage results, how-
ever, precluded our ability to analyze the influence
of demographic and socioeconomic factors, such
as urban/rural residence, geographical access, ma-
ternal and parental education level and employment,
on the coverage. Many studies showed that the lower
mother’s education level is associated with lower
immunization coverage. Demographic factors, such
as parent’s employment, distance to health service,
and socioeconomic level show less consistent as-
sociation.8-12 In this study, neither parents’ educa-
tion nor demographic factor are associated with the
coverage. In our study the influence of education level
may be overwhelmed by good accessibility to infor-
mation on vaccination. It may partly reflect the role
of health worker in making the community aware on
the importance of vaccination. The relatively small
size of this province also facilitates access to infor-
mation and immunization services.
In term of place of immunization, while children
in urban area mostly received immunization in pri-
mary health center (64.8%), in rural areas private
midwife practice is being the main place (56.9%),
and then just followed by primary health center
(37.4%). This fact is especially interesting consid-
ering that the immunization service in private mid-
wife is not free of charge, in contrast with that of in
primary health center. Additional interview during the
survey revealed that flexibility in service time for im-
munization is the main reason for parents to choose
the private midwife practices. In fact, the private mid-
wives usually provide immunization service in looser
schedule and even in many cases they open the
service during holidays. The data suggest that the
time flexibility overweight the consequence for pay-
ing the service. However, we have no further informa-
tion to explain why this preference, surprisingly, pre-
dominantly exists in rural, rather than in urban ar-
eas. With a general assumption that the respon-
dents in urban area have higher income and posing
more busy life rhythm, this phenomenon should be
viewed in other perspective. It is probably that under
the local culture, the community has more personal
and psychological attachment with the midwives
compared with the primary health center or other
health center as an institution, though most of mid-
wives also serve as personnel in PHC or hospital/
clinics.
Some previous studies indicated that high vac-
cination coverage does not necessarily imply timely
vaccination. It is shown that vaccination coverage
alone is not a good indicator for age-appropriate vac-
cination.13-15 During the IPV pilot project in Yogyakarta
Province, the Ministry of Health recommended the
vaccine to be administered at 2, 3, 4, and 9 months
old. The first three doses are administered together
with combined DTP-Hepatitis B vaccine, while the
fourth dose with measles vaccine.  Some children
may receive IPV in combined form with DPaT or
DPaT+Hib, which are not subsided by EPI program.
In this case, they may follow the schedule with on
2-month-interval (at 2, 4, and 6 months old), and the
fourth dose at 9 months old simultaneously with
measles vaccine. In assessing the timeliness of IPV
administration we look at the mean age of adminis-
tration and that the first dose should not be given at
age less than 6 weeks and the minimum interval
between doses is 4 week (28 days). Doses given
within 4 days before the minimum age, thus at inter-
val 24 day or more, are considered accepTable.16
We do not include the delay of vaccination as indi-
cator for timeliness since, unlike in AAP recommen-
dation, the Indonesian national EPI schedule does
not strictly define the longest interval between IPV
doses that remain accepTable. Moreover, there is
schedule recommended by the IPS that uses an
optimal interval between doses of 8 weeks, instead
of a minimum interval of 4 weeks as in the national
EPI recommendation. This difference complicates
us in determining the definition of delay of IPV im-
munization for this study. In this study, the mean
ages of IPV administration are very close to the rec-
ommended schedule (2.3, 3.5, 4.8, and 9.4 months
for IPV1, IPV2, IPV3, and IPV4, respectively). In our
population, only few children (<5%) received IPV
vaccination inappropriately (too early administration
of the first dose and to close interval between doses).
Too early administration and too close spacing be-
tween doses of IPV would result in suboptimal im-
mune response. In our study, more than 95% chil-
dren get the IPV immunization timely, higher than
that shown in several studies in other countries. As
comparison, the timely polio vaccination in Uganda
(using OPV) for doses 1-3 ranged between 67-81%.17
A study in United States18 showed approximately
32% children receiving IPV beyond the recom-
mended schedule. However, this study included the
immunization delay as one of indicator for inappro-
priate immunization. Timely vaccination, beside its
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high coverage, prevents the children from unprotected
space, in which they would pose higher risk for get-
ting infection.
The present study strongly indicated that the
pilot IPV immunization in Yogyakarta Province has
been implemented with high compliance and punc-
tuality. This result, in couple with that of seropre-
valence study that was carried out separately, pro-
vides strong message to all stakeholders for the fea-
sibility of the IPV program to be continued in
Yogyakarta Province. This success experience will
be a good lesson for other regions in Indonesia when
the time for switching to IPV immunization comes.
To conclude, the pilot program of IPV immuni-
zation in Yogyakarta Province has been well imple-
mented with impressive coverage and timeliness and
is comparable with that of the previous live oral polio
vaccine (OPV). The shift from oral live polio vaccine
to the current inactivated polio vaccine does not com-
promise the coverage, partly indicating a high ac-
ceptance of the IPV immunization.
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